Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study
Launched by NINGBO EYE HOSPITAL · Sep 11, 2022
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Slit-lamp images with sufficient diagnostic certainty and showing keratitis at the active phase.
- Exclusion Criteria:
- • Poor-quality images
- • Images presenting mixed infections (i.e., cornea infected by two or more causative pathogens)
About Ningbo Eye Hospital
Ningbo Eye Hospital is a leading medical institution specializing in ophthalmology, dedicated to advancing eye care through innovative research and clinical excellence. With a focus on patient-centered treatments and cutting-edge technologies, the hospital actively participates in clinical trials aimed at improving surgical techniques, developing new therapies, and enhancing diagnostic methods for various eye conditions. Committed to fostering collaboration and knowledge sharing, Ningbo Eye Hospital strives to contribute to the global body of ophthalmic research while ensuring the highest standards of patient safety and care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ningbo, Zhejiang, China
Wenzhou, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials